What's new

Human medicines European public assessment report (EPAR): Spinraza, nusinersen, Date of authorisation: 30/05/2017, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Spinraza, nusinersen, Date of authorisation: 30/05/2017, Revision: 18, Status: Authorised

Feb 27, 2025 - 10:29
 0
Human medicines European public assessment report (EPAR): Spinraza, nusinersen, Date of authorisation: 30/05/2017, Revision: 18, Status: Authorised
Human medicines European public assessment report (EPAR): Spinraza, nusinersen, Date of authorisation: 30/05/2017, Revision: 18, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Xalkori, crizotinib, D...

Next Article

The Value of Device Characterization for the Optimization of Organic Solar Cells

Related Posts

Recommendations on eligibility to PRIME scheme - Adopte...

Feb 9, 2025  0

European Medicines Agency procedural advice for users o...

Feb 24, 2025  0

Minimum inhibitory concentration (MIC) breakpoints

Feb 21, 2025  0